dsdsa

product

High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

With our abundant experience and considerate products and services, we have been recognized to be a reputable supplier for a lot of global consumers for Sildenafil Citrate Powder, Procaine, Dapagliflozin Propanediol Monohydrate, Please feel free to contact us at any time. We will reply you when we receive your inquiries. Please note that samples are available before we start our business.
High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai Detail:

Product name AZD-9291 mesylate
Synonyms N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1)
CAS No. 1421373-66-1
Appearance White to light yellow solid powder
Molecular Formula C28H33N7O2.CH4O3S
Molecular Weight 595.71
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

AZD-9291 mesylate CAS:1421373-66-1

Items

Standards

Results

Appearance

White to light yellow solid powder

Light yellow solid powder

Identification

By IR

Complies

By HPLC

Complies

Solubility

Soluble in Dimethylsulfoxide,slightly soluble in Ethanol and Acetonitrile,with pH dependent aqueous solubility

Complies

Water Content(KF)

≤ 1.00%

0.42%

Residue on Ignition

≤ 0.10%

0.05%

Heavy Metal

≤ 20ppm

Complies

Mesylate

15.20%~18.20%

15.90%

Residual Solvents

Acetonitrile: ≤410ppm

ND

Acetone: ≤5000ppm

ND

Tetrahydrofuran: ≤720ppm

ND

Related Substances

Maximum single impurity: ≤0.20%

0.17%

Total impurities: ≤1.00%

0.25%

Particle Size

D90: ≤100μm

57.97%

Assay

(HPLC basis on drying)

98.00%~102.00%

99.80%

Reference Standard

In-house Standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures

High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures

High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures


Related Product Guide:

We usually keep on with the principle "Quality To start with, Prestige Supreme". We've been fully committed to offering our purchasers with competitively priced excellent solutions, prompt delivery and skilled support for High reputation Lenvatinib - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai , The product will supply to all over the world, such as: Czech, Dominica, Brunei, Based on products and solutions with high quality, competitive price, and our full range service, we have accumulated experienced strength and experience, and we've built up a very good reputation in the field. Along with the continuous development, we commit ourselves not only to the Chinese domestic business but also the international market. May you moved by our high quality items and passionate service. Let's open a new chapter of mutual benefit and double win.
  • It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
    5 Stars By Nora from Washington - 2018.06.09 12:42
    High Quality, High Efficiency, Creative and Integrity, worth having long-term cooperation! Looking forward to the future cooperation!
    5 Stars By Queena from Norwegian - 2017.08.28 16:02
    Write your message here and send it to us